Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
about
Neuroplasticity and the next wave of antidepressant strategiesKetamine use in current clinical practiceTreatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as TherapyKetamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on EfficacyPotential of Glutamate-Based Drug Discovery for Next Generation AntidepressantsBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewChallenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsPharmacological approaches to the challenge of treatment-resistant depressionAntidepressant mechanism of ketamine: perspective from preclinical studiesContribution of NMDA receptors to dorsolateral prefrontal cortical networks in primatesKetamine, sleep, and depression: current status and new questionsAntidepressant actions of ketamine: from molecular mechanisms to clinical practiceSignal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood DisordersKetamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacyA brief history of the development of antidepressant drugs: from monoamines to glutamateImmune and Neuroendocrine Mechanisms of Stress Vulnerability and ResilienceCase Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing l-DOPA-Induced DyskinesiasA neurocognitive model for understanding treatment action in depressionThe positive effect on ketamine as a priming adjuvant in antidepressant treatment.Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.Glutamate and its receptors in the pathophysiology and treatment of major depressive disorderA pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain.Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.A randomized controlled trial of intranasal ketamine in major depressive disorder.Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects.Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in miceKetamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeuticsThe role of ketamine in treatment-resistant depression: a systematic review.Glutamate NMDA receptor modulators for the treatment of depression: trials and tribulations.Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.Investigational drugs in recent clinical trials for treatment-resistant depression.Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.Repeated S-ketamine infusions in therapy resistant depression: a case series.Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
P2860
Q21129480-31DD4622-919A-48A2-8674-2183BAA14CE2Q26750682-E921E5E6-48D2-4C6A-91B8-0B31192348FEQ26773084-9C1CEEE2-DAAF-4E13-8B59-C8E661CEEC84Q26778251-4613ABC5-E133-4D68-9E19-5DE93019EAE5Q26782274-6409741D-E03A-439A-8EDF-4A899B7197EBQ26782993-F0ED7582-3C07-48A3-BE12-432846B0EA32Q26782997-CEF2A01A-8ED3-439B-9551-8A27C7D4F378Q26798241-9ED2D319-C745-47EE-B8B9-D72B90BC342CQ26800231-BE2CFB0A-4629-4A89-8EBE-F8933A2532CCQ26820417-53530530-61C0-4C4E-87E9-E006095D06C6Q26828564-117C1B84-561A-4608-A2FC-7C0230A51A50Q26995879-20498828-98E1-45AC-BB1E-A682C49453D2Q27006485-12FEE688-1616-41D0-91BB-7D7B653F6664Q27024227-8092DD16-ED1E-40A2-B129-7FC4CA049699Q27028050-21832181-05C8-44A0-9236-90E86B1E8D46Q28396103-E857CA6F-0734-4422-97F4-032D109CE239Q28828342-3E758730-DEDA-4960-879C-67D440E9BED4Q30374324-73BEF58A-EA07-4B90-9749-8637F868CBE6Q30408646-ED3AC796-6BF3-4DB0-97D8-C674A9610397Q30547324-10F5002D-C54C-4977-85E8-26E005E25B0DQ30711088-197498FE-941E-4953-A538-CC3FDF896147Q30987882-548993B4-6AE2-4826-BF71-C89DF6E799AEQ33693374-CCA90C99-A7D2-4045-BBEA-CB1AC06C59F3Q33758450-1354A256-AA7D-4116-8F39-22E0EAF68437Q33864745-CC50C2DB-9E21-40E4-B1AF-4A50EEA5BCDAQ33874459-408FCB6E-736B-44EA-A2E5-FFD23A8613DEQ34241455-C8B463B1-E7C7-43A1-8B34-16E3EF53CE48Q34288196-3130CB44-8EAB-482D-A206-A242CDA4BB3DQ34333515-CA862E36-6E33-492E-9917-233CE98352EFQ34391633-DFD3798A-41F7-46F7-877F-6B31BED05291Q34436340-E8C46471-16C2-45ED-86DD-53282D9B8DFEQ34444632-8A58B159-12A9-4AFF-8B9A-A042F1970210Q34449588-2887F0BA-5724-4223-AEE5-5C617367420BQ34466310-46877C19-4D9E-4658-8361-1557B5C91FE5Q34475595-29D748B6-91F7-46FD-9831-902405D0BF4AQ34549390-22AE2EDA-C3CD-4C0F-B823-DEC27AA30B62Q34551188-DC877E59-9581-4422-A18F-6AB7C9C64D38Q34653386-03C3311A-8425-47EC-9ED4-61A1A5678D3CQ34654747-7F0FE0E2-C51A-4D9D-B8CA-FC01D0E1E1A3Q34655680-E751E062-004C-44AF-BA2D-8DDF937B90C0
P2860
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Rapid and longer-term antidepr ...... nt-resistant major depression.
@ast
Rapid and longer-term antidepr ...... nt-resistant major depression.
@en
Rapid and longer-term antidepr ...... nt-resistant major depression.
@nl
type
label
Rapid and longer-term antidepr ...... nt-resistant major depression.
@ast
Rapid and longer-term antidepr ...... nt-resistant major depression.
@en
Rapid and longer-term antidepr ...... nt-resistant major depression.
@nl
prefLabel
Rapid and longer-term antidepr ...... nt-resistant major depression.
@ast
Rapid and longer-term antidepr ...... nt-resistant major depression.
@en
Rapid and longer-term antidepr ...... nt-resistant major depression.
@nl
P2093
P2860
P1476
Rapid and longer-term antidepr ...... nt-resistant major depression.
@en
P2093
Andrew M Perez
Dan V Iosifescu
Dennis S Charney
James W Murrough
Jessica Stern
Katherine A Collins
Michael K Parides
Sanjay J Mathew
Sarah Pillemer
P2860
P304
P356
10.1016/J.BIOPSYCH.2012.06.022
P407
P577
2012-07-27T00:00:00Z